We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
-1.8%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$2.15B
AUM Growth
+$82.6M
Cap. Flow
+$147M
Cap. Flow %
6.86%
Top 10 Hldgs %
24.87%
Holding
174
New
31
Increased
73
Reduced
40
Closed
27

Top Buys

Rank Stock Value
1
ACHC icon
Acadia Healthcare
ACHC
+$26M
2
FISV
Fiserv Inc
FISV
+$24M
3
OMC icon
Omnicom Group
OMC
+$19.5M
4
OC icon
Owens Corning
OC
+$19.2M
5
MOS icon
The Mosaic Company
MOS
+$18.3M

Top Sells

Rank Stock Value
1
HAE icon
Haemonetics
HAE
+$24.3M
2
BKH icon
Black Hills Corp
BKH
+$19.6M
3
SEE
Sealed Air
SEE
+$15.5M
4
UHS icon
Universal Health Services
UHS
+$15M
5
GOLD
Gold.com Inc
GOLD
+$13.4M

Sector Composition

Rank Sector Weight
1 Technology 20.83%
2 Healthcare 17.07%
3 Consumer Discretionary 14.96%
4 Materials 11.78%
5 Industrials 11.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JILL icon
126
J. Jill
JILL
$279M
$2.79M 0.13%
203,227
+3,161
+2% +$47.8K
DSP icon
127
Viant Technology
DSP
$282M
$2.75M 0.13%
+228,216
New +$2.28M
SPT icon
128
Sprout Social
SPT
$604M
$2.74M 0.13%
243,112
-5,524
-2% -$59.6K
CMCSA icon
129
Comcast
CMCSA
$89.4B
$2.63M 0.12%
+87,897
New +$2.51M
MHK icon
130
Mohawk Industries
MHK
$9.19B
$2.22M 0.1%
+20,326
New +$2.33M
TITN icon
131
Titan Machinery
TITN
$426M
$2.21M 0.1%
+146,793
New +$2.36M
FORR icon
132
Forrester Research
FORR
$221M
$2.1M 0.1%
258,733
-5,880
-2% -$46.2K
TBI
133
Trueblue
TBI
$323M
$2.01M 0.09%
442,225
+166,660
+60% +$855K
HURC icon
134
Hurco Companies Inc
HURC
$141M
$1.92M 0.09%
124,575
-1,662
-1% -$27.5K
AVD icon
135
American Vanguard Corp
AVD
$65.5M
$1.69M 0.08%
443,297
-10,074
-2% -$47.1K
EAF icon
136
GrafTech
EAF
$205M
$1.64M 0.08%
105,680
-1,355
-1% -$20.6K
RMAX icon
137
RE/MAX Holdings
RMAX
$243M
$1.57M 0.07%
206,973
-4,704
-2% -$38.2K
UFI icon
138
UNIFI
UFI
$129M
$1.49M 0.07%
426,281
-5,690
-1% -$22K
IPAR icon
139
Interparfums
IPAR
$3.83B
$1.33M 0.06%
+15,724
New +$1.38M
VNT icon
140
Vontier
VNT
$4.63B
$1.32M 0.06%
+35,396
New +$1.35M
WLY icon
141
John Wiley & Sons Class A
WLY
$2.62B
$866K 0.04%
+28,270
New +$996K
MDY icon
142
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27B
$481K 0.02%
797
– –
PRPL icon
143
Purple Innovation
PRPL
$39.6M
$432K 0.02%
25,026
-569
-2% -$11.4K
TLT icon
144
CALL
iShares 20+ Year Treasury Bond ETF
TLT
$40.5B
$305K 0.01%
+3,500
New +$313K
LEXX icon
145
Lexaria Bioscience
LEXX
$9.07M
$291K 0.01%
31,394
-419
-1% -$5.95K
ASHR icon
146
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.59B
$243K 0.01%
7,388
– –
CALF icon
147
Pacer US Small Cap Cash Cows 100 ETF
CALF
$3.87B
$214K 0.01%
4,822
– –
GOLD
148
Gold.com Inc
GOLD
$1.26B
– –
-519,707
Closed -$13.4M
ARKK icon
149
PUT
ARK Innovation ETF
ARKK
$6.37B
– –
-1,200,000
Closed -$104M
ASH icon
150
Ashland
ASH
$3.45B
– –
-147,482
Closed -$7.07M
3 4 5
6
7

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Invenomic Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Invenomic Capital Management held 174 positions worth $2.15B, up 4% from $2.07B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Invenomic Capital Management deployed $147M of net new capital in Q4 2025, opening 31 new positions and adding to 73 existing holdings. Its largest new stake was Fiserv Inc: 287,266 shares worth $19.3M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Verizon, an estimated $13.2M trimmed.

  • Invenomic Capital Management's largest Q4 2025 buy was Fiserv Inc: 287,266 shares worth $19.3M.
  • Invenomic Capital Management added most to Acadia Healthcare in Q4 2025, an estimated $26M increase.
  • Invenomic Capital Management's biggest Q4 2025 reduction was Verizon, cutting an estimated $13.2M.
  • Invenomic Capital Management fully exited Haemonetics in Q4 2025, selling an estimated $24.3M.
  • Invenomic Capital Management's ten largest holdings make up 25% of its $2.15B portfolio in Q4 2025.
  • Invenomic Capital Management opened 31 new positions and closed 27 in Q4 2025.
  • Invenomic Capital Management's portfolio value rose 4% quarter-over-quarter to $2.15B.

Based on Invenomic Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.